logo
  • Company
    • About
    • Careers
    • News
    • Honors & Awards
  • Solutions
    • The Galen™ Platform
      • First Read
      • Second Read
    • Ibex Precision Medicine
  • Technology
  • Media
    • Blog
    • Media Library
  • Early Adopter Program
  • Contact Us
logologo
  • Company
    • About
    • Careers
    • News
    • Honors & Awards
  • Solutions
    • The Galen™ Platform
      • First Read
      • Second Read
    • Ibex Precision Medicine
  • Technology
  • Media
    • Blog
    • Media Library
  • Early Adopter Program
  • Contact Us
  • Company
    • About
    • Careers
    • News
    • Honors & Awards
  • Solutions
    • The Galen™ Platform
      • First Read
      • Second Read
    • Ibex Precision Medicine
  • Technology
  • Media
    • Blog
    • Media Library
  • Early Adopter Program
  • Contact Us

News

banner
  • Home
  • Company
  • News
Maya Melamed,January 7, 2021

AI Cancer Diagnostics Leader Ibex Medical Analytics Expands to the Americas with Appointment of Joel Duckworth

Digital pathology industry veteran, Joel Duckworth will lead Ibex’s growth in the Americas as Chief Revenue Officer

Read More
Maya Melamed,December 16, 2020

World’s First AI-Solution for Primary Diagnosis of Breast Cancer Deployed by Ibex Medical Analytics and KSM, the Research and Innovation Center of Maccabi Healthcare Services

Ibex’s Galen™ Breast is rolled out as a first read application, helping pathologists improve accuracy, reduce turnaround time and streamline reporting

Read More
Maya Melamed,December 3, 2020

Ibex Medical Analytics and Institut Curie Partner to Improve AI-Powered Breast Cancer Detection

Globally renowned oncology center Institut Curie is leading a study on Ibex’s  Galen™ Breast, the first AI-based solution used by pathologistsb in routine clinical practice for breast cancer detection.

Read More
Maya Melamed,November 24, 2020

Ibex Medical Analytics Welcomes Dr. David Shulkin, Former Secretary of the VA, and Joe Robinson to its Advisory Board

Ibex strengthens its focus on the US market with seasoned health executives to accelerate delivery of its AI-powered cancer diagnosis vision to healthcare networks, payors and policy makers

Read More
Maya Melamed,November 5, 2020

Ibex Medical Analytics, the Leader in AI-Powered Cancer Diagnostics, is now ISO 13485 Certified

The ISO 13485 certification validates Ibex Medical Analytics’ position as a leading and quality-focused solution provider for healthcare organizations

Read More
Maya Melamed,September 22, 2020

Ibex Medical Analytics Wins UK Award to Accelerate Adoption of AI powered Cancer Detection in the NHS

Ibex was selected among the first ever winners of the AI in Health and Care Award, sharing £50 million to enable a study of Ibex’s AI technology across multiple NHS trusts

Read More
Maya Melamed,September 1, 2020

First U.S. Lab Implements AI-based Solution for Cancer Detection in Pathology

CorePlus completes deployment of Ibex Medical Analytics’ Galen™ Prostate solution to support pathologists in accurate diagnosis, enhanced lab efficiency and quality control

Read More
Maya Melamed,July 28, 2020

The Lancet Reports Outstanding Performance of Ibex Medical Analytics’ AI-based Algorithm in a Study at UPMC

The Lancet Reports Outstanding Performance of Ibex Medical Analytics’ AI-based Algorithm in a Study at UPMC

Read More
Maya Melamed,July 21, 2020

New Milestone for Cancer Diagnostics in France as Ibex Medical Analytics Deploys its AI-Based Technology for Pathology at Medipath

New Milestone for Cancer Diagnostics in France as Ibex Medical Analytics Deploys its AI-Based Technology for Pathology at Medipath

Read more
Maya Melamed,June 30, 2020

UK’s First Rollout of AI-based Cancer Detection for NHS Patients as Pathology Provider LDPath Teams Up with Ibex Medical Analytics

UK’s First Rollout of AI-based Cancer Detection for NHS Patients as Pathology Provider LDPath Teams Up with Ibex Medical Analytics

Read more
Maya Melamed,February 27, 2020

Ibex Obtains CE-IVD Mark for AI-Powered Cancer Detection

Ibex’s Galen™ Prostate solution demonstrates outstanding results in a blinded study and supports pathologists in providing accurate diagnosis, enhanced lab efficiency and quality control

Read More
Maya Melamed,December 4, 2019

The Ibex Second Read™ System for breast is now deployed at Maccabi’s pathology institute, making it the first lab in the world to implement AI-powered cancer diagnostics for breast biopsies in its routine clinical practice

The Ibex Second Read™ System for breast is now deployed at Maccabi's pathology institute, making it the first lab in the world to implement AI-powered cancer diagnostics for breast biopsies in its routine clinical practice

Read More
Maya Melamed,October 30, 2019

Stuart Shand Joins Ibex Medical Analytics as Chief Commercial Officer

Stuart Shand Joins Ibex Medical Analytics' management team as Chief Commercial Officer. Shand’s extensive experience in the digital pathology market will help grow the company’s business

Read More
Maya Melamed,September 9, 2019

Inspirata and IBEX Medical Analytics Announce New Technical Partnership at the European Congress of Pathology enabling joint customers to utilise artificial intelligence-based image analysis to reduce cancer case turnaround time and mitigate diagnostic errors

Inspirata and IBEX Medical Analytics announce new technical partnership at the European Congress of Pathology (ECP) enabling joint customers to utilise artificial intelligence-based image analysis to reduce cancer case turnaround time and mitigate diagnostic errors.

Read More
Maya Melamed,September 9, 2019

Ibex Medical Analytics is among DigitalHealth.London’s 20 new digital health care innovators

Ibex Medical Analytics is among DigitalHealth.London's 20 new digital health care innovators. The prestigious accelerator has recently announced the innovators to be supported by the 2019-20 program at a launch event in central London.

Read more
Maya Melamed,September 4, 2019

Ibex Medical Analytics and Medipath engage in a strategic partnership to unleash the power of Artificial Intelligence in Medipath’s pathology labs in France

Ibex Medical Analytics, a pioneer in Artificial Intelligence-based cancer diagnostics, and Medipath, the largest network of private pathology labs in France, announce today a partnership, designed to introduce artificial intelligence to the workflow in Medipath’s pathology labs and co-develop the next generation of Ibex’s product suite.

Read More
Maya Melamed,August 7, 2019

Dr. Ajit Singh Joins Ibex Medical Analytics’ Advisory Board, where his extensive experience in medical technologies will help grow the company’s AI-based solutions footprint in pathology labs

Ibex Medical Analytics, the pioneer in artificial intelligence (AI)-based cancer diagnostics, announces today that Dr. Ajit Singh, managing director of Artiman Ventures, a Silicon Valley based VC firm, is joining its advisory board.

Read More
Maya Melamed,August 5, 2019

IBEX: AI-POWERED CANCER DETECTION

Hillel's tech corner column on the Jerusalem post covering Ibex's work in the area of AI-based cancer diagnostics

Read More
Maya Melamed,April 2, 2019

Computational Pathology Pioneer Ibex Raises $11M

Ibex Medical Analytics, a pioneering developer of AI-driven computational pathology cancer diagnosis system, completed an $11 million Series A funding round led by aMoon Fund.

Read More
Maya Melamed,March 5, 2019

Health Providers Are Developing AI-Enabled Pathology Tools

The latest developments in the work done by health Providers around the development of AI-Enabled Pathology Tools

Read More
Maya Melamed,July 24, 2018

Ibex Medical Analytics and UPMC Join Forces for Advancing AI-based Prostate Cancer Diagnostics

Ibex Medical Analytics and UPMC join forces for advancing AI-based prostate cancer diagnostics.

Read More
kupes,April 19, 2018

Ibex Medical Analytics deploys the first ever AI-based digital pathology cancer diagnosis system in live clinical setting

Ibex Medical Analytics deploys the first ever AI-based digital pathology cancer diagnosis system in live clinical setting, with immediate impact on patient care.

Read More
kupes,April 17, 2018

Maccabi Healthcare Services recently started leveraging Ibex Medical Analytics’ Second Read system.

Maccabi Healthcare Services, which runs a pathology institute responsible for 160,000 histology accessions every year, recently started leveraging Ibex Medical Analytics’ Second Read system.

Read More

©2020 Ibex Medical Analytics Ltd.All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Join Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy